| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.117 | 15.142 | 17.425 | 16.771 | 7.976 | 19.111 | 27.432 | 35.845 | 38.870 | 52.552 |
| Total Income - EUR | 12.118 | 15.143 | 17.437 | 16.775 | 7.989 | 19.117 | 27.436 | 35.846 | 38.870 | 52.552 |
| Total Expenses - EUR | 11.429 | 4.912 | 15.701 | 15.178 | 7.814 | 15.262 | 20.877 | 31.008 | 32.766 | 40.406 |
| Gross Profit/Loss - EUR | 689 | 10.232 | 1.736 | 1.597 | 175 | 3.855 | 6.559 | 4.838 | 6.104 | 12.146 |
| Net Profit/Loss - EUR | 325 | 9.929 | 1.540 | 1.383 | 88 | 3.664 | 6.284 | 4.479 | 5.715 | 10.806 |
| Employees | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Cerebromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.498 | 25.287 | 23.452 | 21.640 | 19.866 | 19.379 | 16.978 | 14.792 | 14.747 | 16.068 |
| Current Assets | 16.163 | 5.376 | 8.454 | 9.665 | 3.994 | 2.426 | 15.153 | 29.278 | 29.535 | 30.146 |
| Inventories | 0 | 0 | 444 | 436 | 428 | 420 | 1.900 | 10.066 | 10.735 | 14.059 |
| Receivables | 2.774 | 2.366 | 2.097 | 1.476 | 2.774 | 1.324 | 2.994 | 4.526 | 7.675 | 4.897 |
| Cash | 13.389 | 3.010 | 5.913 | 7.752 | 793 | 683 | 10.259 | 14.686 | 11.126 | 11.190 |
| Shareholders Funds | 11.655 | 21.465 | 1.903 | 3.251 | 3.276 | 6.878 | 13.010 | 17.530 | 23.192 | 33.868 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.006 | 9.198 | 30.003 | 28.054 | 24.450 | 14.927 | 19.121 | 26.540 | 21.090 | 12.345 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cerebromed Srl